Hong Jun Liang
Directeur/Bestuurslid bij BEIJING STRONG BIOTECHNOLOGIES,INC.
Actieve functies van Hong Jun Liang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Directeur/Bestuurslid | 13-08-2020 | - |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Directeur/Bestuurslid | 15-09-2020 | - |
Loopbaan van Hong Jun Liang
Eerdere bekende functies van Hong Jun Liang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| JIANGSU HENGRUI MEDICINE CO., LTD. | Directeur/Bestuurslid | 13-11-2018 | 01-01-2020 |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Voorzitter | - | 15-11-2019 |
Statistieken
Internationaal
| China | 5 |
Operationeel
| Director/Board Member | 3 |
| Chairman | 1 |
Sectoraal
| Health Technology | 4 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
| JIANGSU HENGRUI MEDICINE CO., LTD. | Health Technology |
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Beurs
- Insiders
- Hong Jun Liang
- Ervaring
